<!DOCTYPE html>
<html>
<head>
<title>USANA Health Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)</title>
<link href="/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
<script type="text/javascript" src="/javascripts/ir.js"></script>
<link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.min.js"></script>
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.js"></script>
</head>
<body>
<style>
body {
font-family: Arial, Helvetica, sans-serif;
font-size: 12px;
color: #454545;
}
</style>
<div class="xbrl-content">
    <h3>Quarterly report pursuant to Section 13 or 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item current" href="/sec-filings/all-sec-filings/xbrl_doc_only/1633">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1633">Document And Entity Information</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/sec-filings/all-sec-filings/xbrl_doc_only/1634">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1634">Condensed Consolidated Balance Sheets (Current Period Unaudited)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1635">Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1636">Condensed Consolidated Statements of Comprehensive Income (Unaudited)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1637">Condensed Consolidated Statement of Stockholders' Equity (Unaudited)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1638">Condensed Consolidated Statements of Cash Flows (Unaudited)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/sec-filings/all-sec-filings/xbrl_doc_only/1639">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1639">Note A - Organization, Consolidation, and Basis of Presentation</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1640">Note B - Fair Value Measures</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1641">Note C - Inventories</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1642">Note D - Investment in Equity Securities</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1643">Note E - Revenue and Contract Liabilities</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1644">Note F - Line of Credit</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1645">Note G - Contingencies</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1646">Note H - Derivative Financial Instruments</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1647">Note I - Common Stock and Earnings Per Share</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1648">Note J - Segment Information</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/sec-filings/all-sec-filings/xbrl_doc_only/1649">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1649">Significant Accounting Policies (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/sec-filings/all-sec-filings/xbrl_doc_only/1650">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1650">Note B - Fair Value Measures (Tables)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1651">Note C - Inventories (Tables)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1652">Note E - Revenue and Contract Liabilities (Tables)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1653">Note I - Common Stock and Earnings Per Share (Tables)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1654">Note J - Segment Information (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/sec-filings/all-sec-filings/xbrl_doc_only/1655">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1655">Note B - Fair Value Measures (Details Textual)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1656">Note B - Fair Value Measures - Schedule Of Assets And Liabilities Measured At Fair Value (Details)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1657">Note C - Inventories - Schedule of Inventories (Details)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1658">Note D - Investment in Equity Securities (Details Textual)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1659">Note E - Revenue and Contract Liabilities - Schedule of Other Revenue (Details)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1660">Note E - Revenue and Contract Liabilities - Schedule Of Contract Liabilities From Contract With Customers (Details)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1661">Note F - Line of Credit (Details Textual)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1662">Note H - Derivative Financial Instruments (Details Textual)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1663">Note I - Common Stock and Earnings Per Share (Details Textual)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1664">Note I - Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1665">Note I - Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1666">Note J - Segment Information (Details Textual)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1667">Note J - Segment Information - Schedule of Revenue Percentage By Product (Details)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1668">Note J - Segment Information - Revenues From External Customers by Geographical Areas (Details)</a></li>
                                                            <li><a href="/sec-filings/all-sec-filings/xbrl_doc_only/1669">Note J - Segment Information - Consolidated Net Sales and Long Lived Assets (Details)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>Document And Entity Information</h4>
                <div style="clear:both;"></div>
    </div>
</div>
</body>
</html>